<VariationArchive VariationID="845216" VariationName="NM_000321.3(RB1):c.98dup (p.Glu34fs)" VariationType="Duplication" Accession="VCV000845216" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2020-04-15" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="840901" VariationID="845216">
      <GeneList>
        <Gene Symbol="RB1" FullName="RB transcriptional corepressor 1" GeneID="5925" HGNC_ID="HGNC:9884" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q14.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="48303751" stop="48481890" display_start="48303751" display_stop="48481890" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="48877882" stop="49056025" display_start="48877882" display_stop="49056025" Strand="+" />
          </Location>
          <OMIM>614041</OMIM>
          <Haploinsufficiency last_evaluated="2021-03-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RB1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-03-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RB1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000321.3(RB1):c.98dup (p.Glu34fs)</Name>
      <CanonicalSPDI>NC_000013.11:48304007:CCC:CCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>13q14.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="48304007" stop="48304008" display_start="48304007" display_stop="48304008" variantLength="1" positionVCF="48304007" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="48878143" stop="48878144" display_start="48878143" display_stop="48878144" variantLength="1" positionVCF="48878143" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
      </Location>
      <ProteinChange>E34fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.48878146dup" Assembly="GRCh37">
            <Expression>NC_000013.10:g.48878146dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.48304010dup" Assembly="GRCh38">
            <Expression>NC_000013.11:g.48304010dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009009.1" sequenceAccession="NG_009009" sequenceVersion="1" change="g.5264dup">
            <Expression>NG_009009.1:g.5264dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000321.3" sequenceAccession="NM_000321" sequenceVersion="3" change="c.98dup" MANESelect="true">
            <Expression>NM_000321.3:c.98dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000312.2" sequenceAccession="NP_000312" sequenceVersion="2" change="p.Glu34fs">
            <Expression>NP_000312.2:p.Glu34fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_517" sequenceAccession="LRG_517">
            <Expression>LRG_517:g.5264dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_517t1" sequenceAccession="LRG_517t1">
            <Expression>LRG_517t1:c.98dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1952054473" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000321.3(RB1):c.98dup (p.Glu34fs) AND Retinoblastoma" Accession="RCV001048241" Version="8">
        <ClassifiedConditionList TraitSetID="3557">
          <ClassifiedCondition DB="MedGen" ID="C0035335">Retinoblastoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-05-16" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17096365</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3557" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6463" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Retinoblastoma</ElementValue>
                <XRef ID="2161" DB="GeneTests" />
                <XRef ID="Retinoblastoma/6282" DB="Genetic Alliance" />
                <XRef ID="HP:0009919" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0008380" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Eye cancer, retinoblastoma</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RETINOBLASTOMA, SOMATIC</ElementValue>
                <XRef Type="Allelic variant" ID="614041.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0001" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RB1</ElementValue>
                <XRef Type="MIM" ID="180200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RB</ElementValue>
                <XRef Type="MIM" ID="180200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors.</Attribute>
                <XRef ID="NBK1452" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000500108" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000597429" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518780" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501237" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502480" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500594" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502581" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522559" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000333054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553202" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528909" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552478" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502479" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521663" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000324949" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Both sporadic and heritable forms are tested.</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7563" />
                <XRef ID="7563" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301625</ID>
                <ID Source="BookShelf">NBK1452</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASHG/ACMG, 1995">
                <ID Source="pmc">1801355</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111019</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">3061998</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASHG/ACMG, 2015">
                <ID Source="PubMed">26140447</ID>
                <ID Source="pmc">4570999</ID>
              </Citation>
              <XRef ID="790" DB="Orphanet" />
              <XRef ID="C0035335" DB="MedGen" />
              <XRef ID="D012175" DB="MeSH" />
              <XRef ID="MONDO:0008380" DB="MONDO" />
              <XRef Type="MIM" ID="180200" DB="OMIM" />
              <XRef Type="primary" ID="HP:0009919" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2377577" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4913877|MedGen:C0035335" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001212234" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17096365</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Glu34Argfs*15) in the RB1 gene. It is expected to result in an absent or disrupted protein product. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant has been observed in an individual affected with bilateral retinoblastoma (RB), as well as his father who had unilateral RB (PMID:¬†17960112). It is also known as g.2157dupC in the literature. Loss-of-function variants in RB1 are known to be pathogenic (PMID: 17096365).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.48878143_48878144insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0035335" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2377577" TraitType="Disease" MappingType="XRef" MappingValue="C0035335" MappingRef="MedGen">
        <MedGen CUI="C0035335" Name="Retinoblastoma" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

